Description

Lucinactant is a synthetic, peptide-containing surfactant designed to mimic the function of natural lung surfactant. This compound is critical for addressing respiratory distress by effectively reducing surface tension in the alveoli. It is primarily required by the pharmaceutical industry for advanced pulmonary research and therapeutic development, particularly for neonatal and acute respiratory conditions.

Application

• Pharmaceutical Active Ingredient: Key component in the formulation of synthetic lung surfactant therapies for the treatment of Respiratory Distress Syndrome (RDS) in premature infants.
• Biomedical Research: Used as a critical reagent in pulmonary physiology studies, surfactant biochemistry, and models of lung injury and repair.
• Drug Delivery Systems: Investigated for use in aerosolized drug delivery platforms to enhance pulmonary absorption and efficacy.
• Therapeutic Development: Serves as a reference standard and a starting material in the R&D of next-generation pulmonary agents for acute lung injury and ARDS (Acute Respiratory Distress Syndrome).

Basic Information

Product Name	Lucinactant
CAS No.	825600-90-6
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	KL4 Surfactant; Sinapultide; Lucinactant (KL4); Synthetic Lung Surfactant KL4; Surfaxin (Brand Name); Peptide-containing Synthetic Surfactant; KL4 Peptide; Lucinactant [USAN]; 825600-90-6
EINECS	Contact for details

Quality Control

Our Lucinactant is manufactured under strict quality systems suitable for pharmaceutical research and development. It undergoes rigorous analytical testing to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing specifications such as peptide content, purity by HPLC, and endotoxin levels are available upon request to support your regulatory and research needs.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as specified on the label. Due to its sensitivity, the product should be handled under an inert atmosphere when opened to prevent oxidation and stored in a dry environment to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder or solid
Identification (HPLC/ MS)	Conforms
Assay (HPLC)	≥ 95.0%
Peptide Content	Contact for details
Water Content (KF)	≤ 5.0%
Residual Solvents (GC)	Meets ICH guidelines
Endotoxin	< 10.0 EU/mg
Biological Activity	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.